ArticleTranslational lung cancer research2024

Tremelimumab and durvalumab with chemotherapy in first-line treatment for metastatic non-small cell lung cancer: a US-based cost-effectiveness analysis.

Ziying Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.